Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bg Medicine Inc (BGMD)

Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bg Medicine Inc 303 Wyman Street Suite 300 Waltham MA 02451 USA

www.bg-medicine.com P: 781-890-1199

Description:

BG Medicine, Inc. operates as a life sciences company focused on the discovery, development, and commercialization of novel diagnostic tests based on biomarkers. The Company is focused on the development of blood-based tests and other candidates for cardiovascular and other diseases. It seeks partnerships with leading diagnostic laboratory instrument manufacturers for the development and commercialization of its products. BG's product candidates include products for Cardiovascular Disease, Central Nervous System (CNS) and Autoimmune Disorders. BG Medicine, Inc. is headquartered in Waltham, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 0
Enterprise Value, $K 0
Shares Outstanding, K 0
Annual Sales, $ 1,570 K
Annual Net Income, $ -5,300 K
EBIT, $ 0 K
EBITDA, $ 0 K
% of Insider Shareholders 6.50%
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Volume Ratio 0.08

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/03/17
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BGMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -337.58%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar